Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raphael Reinbold

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 27, 2022
NADP(H)-dependent biocatalysis without adding NADP(H)Ryan A Herold, Raphael Reinbold, Christopher J Schofield, et al.
Journal of Medicinal Chemistry|March 23, 2023
Differentiating Inhibition Selectivity and Binding Affinity of Isocitrate Dehydrogenase 1 Variant InhibitorsShuang Liu, Martine Abboud, Victor Mikhailov, et al.
Scientific Reports|October 22, 2020
Metampicillin is a cyclic aminal produced by reaction of ampicillin with formaldehydeRaphael Reinbold, Tobias John, Paolo Spingardi, et al.
Scientific Reports|December 5, 2019
Formaldehyde quantification using ampicillin is not selectiveRaphael Reinbold, Tobias John, Paolo Spingardi, et al.
The Journal of Physical Chemistry Letters|June 25, 2021
Exploiting Electrode Nanoconfinement to Investigate the Catalytic Properties of Isocitrate Dehydrogenase (IDH1) and a Cancer-Associated VariantRyan A Herold, Raphael Reinbold, Clare F Megarity, et al.
The Journal of Biological Chemistry|January 9, 2023
Natural and synthetic 2-oxoglutarate derivatives are substrates for oncogenic variants of human isocitrate dehydrogenase 1 and 2Xiao Liu, Raphael Reinbold, Shuang Liu, et al.
Nature Communications|August 15, 2022
Resistance to the isocitrate dehydrogenase 1 mutant inhibitor ivosidenib can be overcome by alternative dimer-interface binding inhibitorsRaphael Reinbold, Ingvild C Hvinden, Patrick Rabe, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Proceedings of the National Academy of Sciences of the United States of America|December 27, 2022
NADP(H)-dependent biocatalysis without adding NADP(H)Ryan A Herold, Raphael Reinbold, Christopher J Schofield, et al.
Journal of Medicinal Chemistry|March 23, 2023
Differentiating Inhibition Selectivity and Binding Affinity of Isocitrate Dehydrogenase 1 Variant InhibitorsShuang Liu, Martine Abboud, Victor Mikhailov, et al.
Scientific Reports|October 22, 2020
Metampicillin is a cyclic aminal produced by reaction of ampicillin with formaldehydeRaphael Reinbold, Tobias John, Paolo Spingardi, et al.
Scientific Reports|December 5, 2019
Formaldehyde quantification using ampicillin is not selectiveRaphael Reinbold, Tobias John, Paolo Spingardi, et al.
The Journal of Physical Chemistry Letters|June 25, 2021
Exploiting Electrode Nanoconfinement to Investigate the Catalytic Properties of Isocitrate Dehydrogenase (IDH1) and a Cancer-Associated VariantRyan A Herold, Raphael Reinbold, Clare F Megarity, et al.
The Journal of Biological Chemistry|January 9, 2023
Natural and synthetic 2-oxoglutarate derivatives are substrates for oncogenic variants of human isocitrate dehydrogenase 1 and 2Xiao Liu, Raphael Reinbold, Shuang Liu, et al.
Nature Communications|August 15, 2022
Resistance to the isocitrate dehydrogenase 1 mutant inhibitor ivosidenib can be overcome by alternative dimer-interface binding inhibitorsRaphael Reinbold, Ingvild C Hvinden, Patrick Rabe, et al.
Pageof 1